Rana P Singh Selected Research

Nestin

2/2011	Silibinin prevents lung tumorigenesis in wild-type but not in iNOS-/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies.
1/2009	Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rana P Singh Research Topics

Disease

94	Neoplasms (Cancer) 01/2024 - 03/2002
32	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2002
29	Carcinoma (Carcinomatosis) 01/2023 - 06/2002
22	Carcinogenesis 01/2024 - 08/2002
16	Body Weight (Weight, Body) 01/2024 - 01/2004
11	Breast Neoplasms (Breast Cancer) 11/2023 - 05/2004
9	Adenocarcinoma 01/2020 - 11/2003
9	Skin Neoplasms (Skin Cancer) 01/2018 - 03/2002
9	Colorectal Neoplasms (Colorectal Cancer) 05/2014 - 10/2006
8	Neoplasm Metastasis (Metastasis) 01/2024 - 06/2003
8	Lung Neoplasms (Lung Cancer) 12/2022 - 06/2006
7	Hypoxia (Hypoxemia) 09/2015 - 09/2006
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 05/2003
4	Papilloma (Papillomatosis) 01/2008 - 03/2002
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2017
3	Inflammation (Inflammations) 08/2019 - 09/2005
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2008 - 12/2003
3	Sunburn 08/2005 - 08/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2005 - 03/2002
2	Atherosclerosis 01/2024 - 01/2005
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024 - 01/2021
2	Glioma (Gliomas) 01/2019 - 09/2003
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2018 - 06/2018

Drug/Important Bio-Agent (IBA)

52	Silybin (Lagosa)IBA 09/2022 - 03/2002
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 09/2003
16	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2003
10	PhytochemicalsIBA 06/2022 - 05/2002
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2003
9	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2014 - 03/2002
9	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2012 - 06/2006
9	Grape Seed ExtractIBA 07/2011 - 11/2002
8	FlavonoidsIBA 08/2019 - 06/2002
8	Phytic Acid (Inositol Hexaphosphate)IBA 02/2009 - 03/2003
8	SilymarinIBA 12/2008 - 03/2002
7	AndrogensIBA 01/2023 - 11/2002
7	fisetinIBA 12/2022 - 02/2012
6	EnzymesIBA 08/2023 - 01/2005
6	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2019 - 11/2003
6	NF-kappa B (NF-kB)IBA 07/2010 - 09/2003
6	CarcinogensIBA 12/2007 - 08/2002
5	Antineoplastic Agents (Antineoplastics)IBA 01/2024 - 02/2005
5	AntioxidantsIBA 03/2018 - 06/2002
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 11/2002
5	CyclinsIBA 01/2017 - 03/2003
5	flavanoneIBA 01/2015 - 12/2003
5	beta CateninIBA 07/2010 - 12/2009
5	Transcription Factors (Transcription Factor)IBA 07/2008 - 09/2004
5	CaspasesIBA 11/2006 - 11/2002
5	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2005 - 03/2002
4	BerberineIBA 01/2024 - 02/2014
4	acacetinIBA 01/2023 - 04/2005
4	Drinking WaterIBA 01/2018 - 12/2007
4	CytokinesIBA 10/2012 - 07/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2012 - 08/2002
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2012 - 06/2006
4	Cyclin D1IBA 01/2010 - 06/2006
4	Insulin-Like Growth Factor Binding Protein 3IBA 12/2007 - 09/2003
3	AlkaloidsIBA 01/2024 - 02/2014
3	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2019
3	diallyl trisulfideIBA 01/2024 - 06/2021
3	Cadherins (E-Cadherin)IBA 08/2023 - 12/2008
3	VimentinIBA 08/2023 - 12/2008
3	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2005
3	ArsenicIBA 01/2018 - 06/2011
3	Cytochromes c (Cytochrome c)IBA 01/2016 - 11/2002
3	Caspase 3 (Caspase-3)IBA 02/2014 - 09/2004
3	AzoxymethaneIBA 09/2010 - 10/2008
3	Matrix Metalloproteinases (MMPs)IBA 12/2008 - 09/2006
3	SurvivinIBA 01/2008 - 12/2003
3	Phosphotransferases (Kinase)IBA 11/2006 - 09/2004
3	Insulin-Like PeptidesIBA 02/2004 - 06/2002
3	milk-thistle extractIBA 12/2003 - 06/2002
2	oxidized low density lipoproteinIBA 01/2024 - 08/2019
2	LigandsIBA 11/2023 - 06/2006
2	Conditioned Culture MediaIBA 11/2023 - 10/2013
2	benzyl isothiocyanateIBA 11/2023 - 01/2016
2	XenobioticsIBA 08/2023 - 09/2005
2	Trypan Blue FDA Link 08/2023 - 05/2003
2	decursinIBA 01/2023 - 02/2005
2	coumarinIBA 01/2023 - 01/2009
2	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2023 - 02/2009
2	Cyclin-Dependent Kinase 4IBA 01/2023 - 09/2004
2	ErbB Receptors (EGF Receptor)IBA 09/2022 - 09/2003
2	RNA (Ribonucleic Acid)IBA 06/2022 - 06/2021
2	Messenger RNA (mRNA)IBA 05/2021 - 12/2003
2	Insulin (Novolin)FDA Link 01/2021 - 09/2010
2	usnic acidIBA 01/2020 - 01/2013
2	ResveratrolIBA 01/2020 - 11/2005
2	ZincIBA 01/2019 - 01/2005
2	Gallic AcidIBA 03/2018 - 07/2006
2	AnthracyclinesIBA 01/2017 - 12/2004
2	matrigelIBA 10/2013 - 02/2004
2	Tyrosine (L-Tyrosine)FDA Link 10/2013 - 11/2005
2	Urethane (Ethyl Carbamate)IBA 02/2011 - 06/2006
2	NestinIBA 02/2011 - 01/2009
2	Glycogen Synthase (Synthase I)IBA 09/2010 - 12/2009

Therapy/Procedure

20	Chemoprevention 01/2016 - 01/2004
13	Therapeutics 01/2024 - 08/2002
3	Drug Therapy (Chemotherapy) 01/2016 - 05/2004
3	Radiotherapy 12/2015 - 11/2011